Biohm Health, Inc. (Cleveland, OH) has unveiled a new corporate brand identity, reflecting the company’s redefined strategy focused on B2B solutions in the nutraceutical industry.  The new corporate identity, Biohm Technologies, includes a fresh look and feel, representing a commitment to the advancement of microbiome innovation for the greater benefit of a wider consumer population, the company stated.

Founded in 2016 by Afif Ghannoum and his father, Dr. Mahmoud Ghannoum, one of the top microbiome researchers in the world, BIOHM Health initially focused on direct-to-consumer offerings revolving around its clinically studied and data-driven BIOHM FX probiotic formulation, according to the company. Dr. Ghannoum’s research on the complex relationship between fungi and bacteria in the gut, fueled in large part by the company’s at-home gut microbiome testing data, is the foundation for Biohm’s innovative solutions in probiotics. “Biohm’s data innovation and resulting probiotic ingredient formulations are well positioned to serve a broader audience through a variety of channels, and that’s been the driving force behind our shift towards amplifying our B2B offerings,” said Sam Schatz, CEO of Biohm.

The entry of Biohm Technologies into an increased B2B focus includes the rebranding of the company’s flagship probiotic blend, originally known as BIOHM FX, now marketed as Mycohsa.  Additionally, the company offers its state-of-the-art, comprehensive microbiome gut testing kits as a private label solution for brands in the health and wellness space looking to provide their customers with greater opportunities to build value and customer intimacy, all powered by Biohm Technologies.

The new brand identity will be unveiled as Biohm Technologies makes its first appearance as an exhibitor at SupplySide West this month.

For more information, visit https://biohmtechnologies.com.